The term of additional protection shall be extended for six months for the invention, the object of which is the active pharmaceutical ingredient of the medicinal product, which has been studied in the field of application for children, the results of which are reflected in the information on the medicinal product authorised by the relevant competent authority referred to in Paragraphs 1 and 2 of this Part.